Abstract
Experiments were performed to study the mechanisms of the sensitivity of normal and neoplastic mouse cells to the cytotoxic action of humoral isoantibodies. A quantitative in vitro absorption procedure was used to compare the residua] hemagglutinin titer of a certain isoantiserum after the absorption of a known volume with known cell numbers. The cell numbers were adjusted so as to yield the same average total cell surface area. Lymph node cells and various solid and ascites tumor cells of strain A and C3H origin were used. It was found that different cell types differed with regard to their concentration of isoantigenic surface receptors. High correlation coefficients were found between the cytotoxic sensitivity and the concentration of isoantigenic receptors. It was shown that tumor cells which were partially or completely resistant to a single isoantiserum could be made sensitive to humoral isoantibodies provided that they were treated with mixtures of antisera, produced in different donor genotypes against the same target genotype, since each individual genotype reacts against a different antigen combination. This supports the concept that cytotoxic sensitivity is related to the surface concentration of reactive sites. Hematopoietic liver cells of newborn mice, which are completely resistant to isoantibodies, and spleen and lymph node cells of adult animals which are highly sensitive, were compared with regard to their ability to take up fluorescein-conjugated normal mouse serum in vitro. No differences were found between their visible pinocytotic uptake. Similar experiments were performed with various ascites tumor cells having different cytotoxic sensitivity. All tumor cells studied had a low pinocytosing ability which was not correlated to their sensitivity to humoral isoantibodies.
Full Text
The Full Text of this article is available as a PDF (1.5 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- FELDMAN M., SACHS L. The antibody response to successful tumor homografts. J Natl Cancer Inst. 1957 Apr;18(4):529–553. [PubMed] [Google Scholar]
- GORER P. A., MIKULSKA Z. B., O'GORMAN P. The time of apperance of isoantibodies during the homograft response to mouse tumours. Immunology. 1959 Jul;2:211–218. [PMC free article] [PubMed] [Google Scholar]
- GORER P. A., MIKULSKA Z. B. The antibody response to tumor inoculation; improved methods of antibody detection. Cancer Res. 1954 Oct;14(9):651–655. [PubMed] [Google Scholar]
- GREEN H., BARROW P., GOLDBERG B. Effect of antibody and complement on permeability control in ascites tumor cells and erythrocytes. J Exp Med. 1959 Nov 1;110:699–713. doi: 10.1084/jem.110.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- JENSEN E., STETSON C. A., Jr Humoral aspects of the immune response to homografts. II. Relationship between the hemagglutinating and cytotoxic activities of certain isoimmune sera. J Exp Med. 1961 Apr 1;113:785–794. doi: 10.1084/jem.113.4.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KALISS N. Immunological enhancement of tumor homografts in mice: a review. Cancer Res. 1958 Oct;18(9):992–1003. [PubMed] [Google Scholar]
- KLEIN E. Immediate transformation of solid into ascites tumors; studies on a mammary carcinoma of an inbred mouse strain. Exp Cell Res. 1955 Feb;8(1):213–225. doi: 10.1016/0014-4827(55)90057-4. [DOI] [PubMed] [Google Scholar]
- KLEIN E. Isoantigenicity of x-ray-inactivated implants of a homotransplantable and a non-homotransplantable mouse sarcoma. Transplant Bull. 1959 Apr;6(2):420–424. doi: 10.1097/00006534-195904000-00032. [DOI] [PubMed] [Google Scholar]
- KLEIN G., REVESZ L., KLEIN E. Experiences with a frozen tumor bank. Transplant Bull. 1957 Jan;4(1):31–33. [PubMed] [Google Scholar]
- LATTA H. A cellular reaction to antibody in tissue culture studied with electron microscopy. J Biophys Biochem Cytol. 1959 May 25;5(3):405–410. doi: 10.1083/jcb.5.3.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LINDER O., KLEIN E. Skin and tumor grafting in coisogenic resistant lines of mice and their hybrids. J Natl Cancer Inst. 1960 Mar;24:707–720. doi: 10.1093/jnci/24.3.707. [DOI] [PubMed] [Google Scholar]
- MTTCHISON N. A., DUBE O. L. Studies on the immunological response to foreign tumor transplants in the mouse. II. The relation between hemagglutinating antibody and graft resistance in the normal mouse and mice pretreated with tissue preparations. J Exp Med. 1955 Aug 1;102(2):179–197. doi: 10.1084/jem.102.2.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RIGGS J. L., SEIWALD R. J., BURCKHALTER J. H., DOWNS C. M., METCALF T. G. Isothiocyanate compounds as fluorescent labeling agents for immune serum. Am J Pathol. 1958 Nov-Dec;34(6):1081–1097. [PMC free article] [PubMed] [Google Scholar]
- SNELL G. D., JACKSON R. B. Histocompatibility genes of the mouse. II. Production and analysis of isogenic resistant lines. J Natl Cancer Inst. 1958 Nov;21(5):843–877. [PubMed] [Google Scholar]
- STETSON C. A., Jr, DEMOPOULOS R. Reactions of skin homografts with specific immune sera. Ann N Y Acad Sci. 1958 Oct 7;73(3):687–692. doi: 10.1111/j.1749-6632.1959.tb40845.x. [DOI] [PubMed] [Google Scholar]
- WEAVER J. M., ALGIRE G. H., PREHN R. T. The growth of cells in vivo in diffusion chambers. II. The role of cells in the destruction of homografts in mice. J Natl Cancer Inst. 1955 Jun;15(6):1737–1767. [PubMed] [Google Scholar]
- WINN H. J. Immune mechanisms in homotransplantation. I. The role of serum antibody and complement in the neutralization of lymphoma cells. J Immunol. 1960 May;84:530–538. [PubMed] [Google Scholar]
- WINN H. J. The immune response and the homograft reaction. Natl Cancer Inst Monogr. 1960 Mar;2:113–138. [PubMed] [Google Scholar]